DIFFERENTIAL EFFECTS OF AMPHETAMINE AND NEUROLEPTICS ON NEGATIVE VS. POSITIVE SYMPTOMS IN SCHIZOPHRENIAANGRIST B; ROTROSEN J; GERSHON S et al.1980; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1980; VOL. 72; NO 1; PP. 17-19; BIBL. 10 REF.Article

HUMAN PLATELET PHOSPHOLIPID METHYLATIONCORDASCO DM; SEGARNICK DJ; ROTROSEN J et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 29; NO 22; PP. 2299-2309; BIBL. 18 REF.Article

STRIATAL ADENYLATE CYCLASE ACTIVITY FOLLOWING RESERPINE AND CHRONIC CHLORPROMAZINE ADMINISTRATION IN RATS. = ACTIVITE ADENYL CYCLASIQUE STRIATALE APRES RESERPINE ET ADMINISTRATION CHRONIQUE DE CHLORPROMAZINE CHEZ LES RATSROTROSEN J; FRIEDMAN E; GERSHON S et al.1975; LIFE SCI.; G.B.; DA. 1975; VOL. 17; NO 4; PP. 563-568; BIBL. 22 REF.Article

A NEUROPSYCHOPHARMACOLOGICAL STUDY OF PHENMETRAZINE IN SEVERAL ANIMAL SPECIES = ETUDE NEUROPSYCHOPHARMACOLOGIQUE DE LA PHENMETRAZINE DANS PLUSIEURS ESPECES ANIMALESWALLACH MB; ROTROSEN J; GERSHON S et al.1973; NEUROPHARMACOLOGY; G.B.; DA. 1973; VOL. 12; NO 6; PP. 541-548; BIBL. 1P.1/2Serial Issue

EFFECTS OF ACUTE COCAINE TREATMENT ON THE TURNOVER OF 5-HYDROXYTRYPTAMINE IN THE RAT BRAIN = EFFETS DU TRAITEMENT AIGU PAR LA COCAINE SUR LE RENOUVELLEMENT DE L'HYDROXY-5 TRYPTAMINE DANS LE CERVEAU DU RATFRIEDMAN E; GERSHON S; ROTROSEN J et al.1975; BRIT. J. PHARMACOL.; G.B.; DA. 1975; VOL. 54; NO 1; PP. 61-64; BIBL. 20 REF.Article

ENKEPHALIN INACTIVATION BY N-TERMINAL TYROSINE CLEAVAGE: PURIFICATION AND PARTIAL CHARACTERIZATION OF A HIGHLY SPECIFIC ENZYME FROM HUMAN BRAINTRAFICANTE LJ; ROTROSEN J; SIEKIERSKI J et al.1980; LIFE SCI.; GBR; DA. 1980; VOL. 26; NO 20; PP. 1697-1706; BIBL. 17 REF.Article

A MORPHANTHRIDINE DERIVATIVE IN SCHIZOPHRENIC PATIENTS-LACK OF EXTRAPYRAMIDAL SYMPTOMS.ANGRIST B; ROTROSEN J; ARONSON M et al.1976; CURR. THERAPEUT. RES.; U.S.A.; DA. 1976; VOL. 20; NO 1; PP. 94-98; BIBL. 1 REF.Article

THE EFFECT OF A NOVEL PSYCHOTROPIC AGENT, TREBENZOMINE ON BRAIN AND PLATELET UPTAKE SYSTEMSFRIEDMAN E; HALLOCK M; ROTROSEN J et al.1981; RES. COMMUN. PSYCHOL. PSYCHIATRY BEHAV.; ISSN 0362-2428; USA; DA. 1981; VOL. 6; NO 4; PP. 289-294; BIBL. 2 P.Article

METOCLOPRAMIDE: ANTIPSYCHOTIC EFFICACY OF A DRUG LACKING POTENCY IN RECEPTOR MODELSSTANLEY M; LAUTIN A; ROTROSEN J et al.1980; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1980; VOL. 71; NO 3; PP. 219-225; BIBL. 31 REF.Article

Murine lymphocytes lack clearly defined receptors for muscarinic and dopaminergic ligandsWAZER, D. E; ROTROSEN, J.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 12, pp 853-854, issn 0022-3573Article

PROSTAGLANDINS, PLATELETS, AND SCHIZOPHRENIAROTROSEN J; MILLER AD; MANDIO D et al.1980; ARCH. GEN. PSYCHIATRY; ISSN 0003-990X; USA; DA. 1980; VOL. 37; NO 9; PP. 1047-1054; BIBL. 65 REF.Article

RAPID IN VITRO SULFOXIDATION OR CHLORPROMAZINE BY HUMAN BLOOD: INHIBITION BY AN ENDOGENOUS PLASMA PROTEIN FACTORTRAFICANTE LJ; SAKALIS G; SIEKIERSKI J et al.1979; LIFE SCI.; GBR; DA. 1979; VOL. 24; NO 4; PP. 337-345; BIBL. 22 REF.Article

ENHANCEMENT OF RESERPINE-ELICITED DOPAMINERGIC SUPERSENSITIVITY BY REPEATED TREATMENT WITH APOMORPHINE AND ALPHA -METHYL-P-TYROSINE. = POTENTIALISATION DE L'HYPERSENSIBILITE DOPAMINERGIQUE PRODUITE PAR LA RESERPINE PAR LE TRAITEMENT REPETE PAR L'APOMORPHINE ET L'ALPHA -METHYL-P-TYROSINEFRIEDMAN E; ROTROSEN J; GURLAND M et al.1975; LIFE SCI.; G.B.; DA. 1975; VOL. 17; NO 6; PP. 867-873; BIBL. 21 REF.Article

PIRACETAM REDUCES ALCOHOL WITH DRAWAL IN MICE WITHOUT POTENTIATING ALCOHOL SEDATIVE EFFECTSSERBY M; SEGARNICK DJ; MANDIO CORDASCO D et al.1982; ALCOHOL. CLIN. EXP. RES.; ISSN 0145-6008; USA; DA. 1982; VOL. 6; NO 4; PP. 520-522; BIBL. 8 REF.Article

ETHANOL AND PROSTAGLANDIN E₁: BIOCHEMICAL AND BEHAVIORAL INTERACTIONSROTROSEN J; MANDIO D; SEGARNICK D et al.1980; LIFE SCI.; GBR; DA. 1980; VOL. 26; NO 22; PP. 1867-1876; BIBL. 30 REF.Article

ANTIBIOTICS AS INHIBITORS OF ENKEPHALIN DEGRADATION BY HUMAN BRAINTRAFICANTE LJ; SIEKIERSKI J; ROTROSEN J et al.1980; PHARMACOL. RES. COMMUNIC.; GBR; DA. 1980; VOL. 12; NO 6; PP. 575-580; BIBL. 11 REF.Article

DETERMINATION OF GLYCINE IN ULTRAFILTRATES OF PLASMA AND RBC LYSATES BY A DANSYLATION THIN-LAYER CHROMATOGRAPHIC METHODDEUTSCH SI; PESELOW ED; TRAFICANTE LJ et al.1981; RES. COMMUN. PSYCHOL. PSYCHIATRY BEHAV.; ISSN 0362-2428; USA; DA. 1981; VOL. 6; NO 3; PP. 193-204; BIBL. 13 REF.Article

A DOUBLE-BLEND COMPARISON OF TREBENZOMINE AND THIORIDAZINE IN THE TREATMENT OF SCHIZOPHRENIAGEORGATAS A; GERBINO L; JORDAN B et al.1981; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1981; VOL. 73; NO 3; PP. 292-294; BIBL. 8 REF.Article

Prostanoid modulation (mediation?) of certain behavioral effects of ethanolSEGARNICK, D. J; MANDIO CORDASCO, D; ROTROSEN, J et al.Pharmacology, biochemistry and behavior. 1985, Vol 23, Num 1, pp 71-75, issn 0091-3057Article

ECT and Parkinson's disease revisited: a naturalistic studyDOUYON, R; SERBY, M; KLUTCHKO, B et al.The American journal of psychiatry. 1989, Vol 146, Num 11, pp 1451-1455, issn 0002-953XArticle

Precursor- and pool-dependent differential effects of ethanol on human platelet prostanoid synthesisSEGARNICK, D. J; RYER, H; ROTROSEN, J et al.Biochemical pharmacology. 1985, Vol 34, Num 8, pp 1343-1346, issn 0006-2952Article

Precursor- and pool-dependent differential effects of ethanol on human platelet prostanoid synthesisSEGARNICK, D. J; RYER, H; ROTROSEN, J et al.Biochemical pharmacology. 1985, Vol 34, Num 8, pp 1343-1346, issn 0006-2952Article

Nifedipine in the treatment of tardive dyskinesiaDUNCAN, E; ADLER, L; ANGRIST, B et al.Journal of clinical psychopharmacology. 1990, Vol 10, Num 6, pp 414-416, issn 0271-0749, 3 p.Article

Amphtamine response and relapse risk after depot neuroleptic discontinuationANGRIST, B; PESELOW, E; RUBINSTEIN, M et al.Psychopharmacologia. 1985, Vol 85, Num 3, pp 277-283, issn 0033-3158Article

Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlatesDOUYON, R; ANGRIST, B; PESELOW, E et al.The American journal of psychiatry. 1989, Vol 146, Num 2, pp 231-234, issn 0002-953XArticle